Literature DB >> 3953503

Pathologic features in the human alimentary tract associated with invasiveness of Candida tropicalis.

T J Walsh, W G Merz.   

Abstract

The pathologic features of Candida albicans and Candida tropicalis in 23 consecutive autopsied patients with culture-proven disseminated candidiasis were studied in order to determine the pathologic basis for the greater virulence of C. tropicalis. Disseminated C. tropicalis infection with gastrointestinal invasion occurred only in eight neutropenic patients; whereas, C. albicans infection occurred in nine neutropenic and six nonneutropenic patients. C. tropicalis involved the entire alimentary tract in four of eight patients versus one of fifteen patients with C. albicans. C. tropicalis penetrated to the deep submucosa in six of eight patients with C. tropicalis and four of fifteen patients with C. albicans. Nine of ten patients with submucosal invasion were neutropenic. Invasion of submucosal blood vessels occurred in six of eight patients with C. tropicalis and only two of fifteen patients with C. albicans. All patients with submucosal blood-vessel invasion were neutropenic. A band of tissue necrosis at the advancing mycelial margin was present with C. tropicalis but not with C. albicans. These autopsy findings indicate that the greater virulence of C. tropicalis is related to increased invasiveness in the gastrointestinal tract in susceptible hosts.

Entities:  

Mesh:

Year:  1986        PMID: 3953503     DOI: 10.1093/ajcp/85.4.498

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  23 in total

1.  Experimental gastrointestinal and disseminated candidiasis in immunocompromised animals.

Authors:  T J Walsh; P A Pizzo
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

Review 2.  Beyond Candida albicans: Mechanisms of immunity to non-albicans Candida species.

Authors:  Natasha Whibley; Sarah L Gaffen
Journal:  Cytokine       Date:  2015-08-11       Impact factor: 3.861

Review 3.  Epidemiology of invasive candidiasis: a persistent public health problem.

Authors:  M A Pfaller; D J Diekema
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

4.  Development of an integrative DNA transformation system for the yeast Candida tropicalis.

Authors:  L O Haas; J M Cregg; M A Gleeson
Journal:  J Bacteriol       Date:  1990-08       Impact factor: 3.490

5.  New features of invasive candidiasis in humans: amyloid formation by fungi and deposition of serum amyloid P component by the host.

Authors:  Kevin B Gilchrist; Melissa C Garcia; Richard Sobonya; Peter N Lipke; Stephen A Klotz
Journal:  J Infect Dis       Date:  2012-07-16       Impact factor: 5.226

Review 6.  Candida tropicalis arthritis in a patient with acute myeloid leukemia successfully treated with fluconazole: case report and review of the literature.

Authors:  G Weers-Pothoff; J F Havermans; J Kamphuis; H A Sinnige; J F Meis
Journal:  Infection       Date:  1997 Mar-Apr       Impact factor: 3.553

Review 7.  Laboratory diagnosis of invasive candidiasis.

Authors:  J M Jones
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

Review 8.  Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.

Authors:  Louis de Repentigny; Daniel Lewandowski; Paul Jolicoeur
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

9.  Candida tropicalis in a neonatal intensive care unit: epidemiologic and molecular analysis of an outbreak of infection with an uncommon neonatal pathogen.

Authors:  Emmanuel Roilides; Evangelia Farmaki; Joanna Evdoridou; Andrea Francesconi; Miki Kasai; Joanna Filioti; Maria Tsivitanidou; Danai Sofianou; George Kremenopoulos; Thomas J Walsh
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

10.  Antifungals: need to search for a new molecular target.

Authors:  A T Sangamwar; U D Deshpande; S S Pekamwar
Journal:  Indian J Pharm Sci       Date:  2008 Jul-Aug       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.